Three-dose vaccination-induced immune responses protect against SARS-CoV-2 Omicron-BA.2
R. Zhou, N. Liu, X. Li, Q. Peng, C.-K. Yiu, H. Huang, D. Yang, Z. Du, H.-Y. Kwok, K.-K. Au, J.-P. Cai, I. F.-N. Hung, K. K.-W. To, X. Xu, K.-Y. Yuen, Z. Chen
This study evaluates the effectiveness of three-dose SARS-CoV-2 vaccination against Omicron BA.2 breakthrough infections and finds that third-dose vaccination significantly reduces infection rates and severity.
bioRxiv · May 9, 2022 · PreprintImmunology